GCC In-vitro Diagnostic Devices Market to Reach USD 1,812.0 Million by 2033, Impelled by Introduction of Advanced In-Vitro Diagnosis Technology

January 07, 2025 | Healthcare

According to the latest report by IMARC Group, titled “GCC In-Vitro Diagnostic Devices Market Report by End-User (Hospital-Based Centers, Diagnostics Chains, Standalone Centers, and Others), Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases, and Others), and Country 2025-2033,” the GCC in-vitro diagnostic devices market reached a value of USD 1,284.0 Million in 2024. In-vitro diagnostic (IVD) devices refer to medical instruments that are used to perform tests using biological samples, such as blood, urine or tissue, taken from the human body. They are available in a wide variety, ranging from simple tests to sophisticated DNA analyzers, including calibrators, kits, software, reagents, control materials and other related instruments. IVD devices play a vital role in the GCC healthcare industry as they are crucial in the diagnosis of various medical conditions and infections, and monitoring drug therapies.

GCC In-vitro Diagnostic Devices Market Trends:

The growing spread of the coronavirus disease (COVID-19) in the GCC countries has significantly boosted the market growth, as the World Health Organization (WHO) has listed two IVD tests for emergency use during the pandemic. These tests include the cobas SARS-CoV-2 Qualitative assay and Real-Time PCR Coronavirus (COVID-19). Additionally, the rising incidences of chronic diseases and the growing geriatric population are further driving the demand for IVD devices. As per the WHO, about 60% of deaths in the GCC countries are caused due to non-communicable diseases, such as diabetes, cancer and cardiovascular dysfunction. This has compelled governments of GCC countries to take initiatives to improve the healthcare services in the region. Some of these initiatives are aimed at investing in improved IVD devices, which are more accurate and efficient in executing diagnostic tests. This, along with the expanding insurance coverage under national health insurance programs, such as the Mandatory Health Insurance (MHI) schemes, to provide better and easy access to diagnostic devices, are boosting the sales of IVD devices across the region. Owing to these factors, the market value is projected to reach USD 1,812.0 Million by 2033, expanding at a CAGR of 3.9% during 2025-2033.

Market Summary:

  • Based on the end-user, the market has been segmented into hospital-based centers, diagnostics chains, standalone centers and others. Amongst these, in-vitro diagnostic devices are majorly used in hospital-based centers.
  • On the basis of the application, the market has been segregated into infectious diseases, diabetes, blood test, nephrology, cardiology, oncology and autoimmune diseases.
  • Region-wise, Saudi Arabia exhibits a clear dominance in the market. Other major regions include the United Arab Emirates, Kuwait, Qatar, Oman and Bahrain.
  • The competitive landscape of the market has been examined in the report with the detailed profiles of the key players operating in the industry.


Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage End User, Application, Country
Countries Covered Saudi Arabia, United Arab Emirates, Qatar, Oman, Kuwait, Bahrain
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
GCC In-vitro Diagnostic Devices Market to Reach USD 1,812.0 Million by 2033, Impelled by Introduction of Advanced In-Vitro Diagnosis Technology
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials